(Q34558618)

3 August 2017

1 reference

title

Strategies for management of prostate cancer-related bone pain (English)

1 reference

3 August 2017

0 references

Pelger RC

1

1 reference

3 August 2017

Soerdjbalie-Maikoe V

series ordinal

2

1 reference

3 August 2017

Hamdy NA

series ordinal

3

1 reference

3 August 2017

publication date

1 January 2001

1 reference

3 August 2017

1 reference

3 August 2017

volume

18

1 reference

3 August 2017

issue

12

1 reference

3 August 2017

page(s)

899-911

1 reference

Generalised increase in bone resorption in carcinoma of the prostate

3 August 2017

cites work

1 reference

12 December 2020

Breast cancer cells interact with osteoblasts to support osteoclast formation

1 reference

12 December 2020

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

1 reference

12 December 2020

Prospective 153Sm-EDTMP therapy dosimetry by whole-body scintigraphy

1 reference

12 December 2020

Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones

1 reference

12 December 2020

Metastatic disease of the spine

1 reference

12 December 2020

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

12 December 2020

Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia

1 reference

12 December 2020

Strontium 89 therapy for the palliation of pain due to osseous metastases

1 reference

12 December 2020

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

1 reference

12 December 2020

Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.

1 reference

12 December 2020

Original article: Prognostic factors in hormone-resistant progressing cancer of the prostate

1 reference

12 December 2020

Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo

1 reference

12 December 2020

Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases

1 reference

12 December 2020

Uptake by Bone of Pyrophosphate, Diphosphonates and their Technetium Derivatives

1 reference

12 December 2020

Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.

1 reference

12 December 2020

Multiple myeloma; a study of 24 patients treated with radioactive isotopes (P32 and SR89)

1 reference

12 December 2020

A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.

1 reference

12 December 2020

Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma

1 reference

12 December 2020

The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer

1 reference

12 December 2020

Bone resorption and turnover in health and disease

1 reference

12 December 2020

THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES

1 reference

12 December 2020

Role of pamidronate in the management of bone metastases from breast cancer: results of a non-comparative multicenter phase II trial. Aredia Multinational Cooperative Group

1 reference

12 December 2020

Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.

1 reference

12 December 2020

Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain

1 reference

12 December 2020

Therapy of metastatic bone pain

1 reference

12 December 2020

Strontium-89 chloride for pain palliation in prostatic skeletal malignancy

1 reference

12 December 2020

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

12 December 2020

Influence of clodronate on breast cancer cells in vitro

1 reference

12 December 2020

Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study

1 reference

12 December 2020

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

1 reference

12 December 2020

Bone metastasis. Prognosis, diagnosis and treatment

1 reference

12 December 2020

Bisphosphonates in the management of prostate carcinoma metastatic to the skeleton

1 reference

12 December 2020

Treatment of skeletal disease in breast cancer: a controlled clodronate trial

1 reference

12 December 2020

Bisphosphonates in prostate carcinoma

1 reference

12 December 2020

Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer

1 reference

12 December 2020

Systemic radionuclide therapy with strontium chloride Sr 89 for painful skeletal metastases in prostate and breast cancer

1 reference

12 December 2020

Increased risk of fatal prostate cancer may explain the rise in mortality in The Netherlands

1 reference

12 December 2020

Osteoporosis after orchiectomy for prostate cancer

1 reference

12 December 2020

Patterns and mechanisms of bone metastases.

1 reference

12 December 2020

Morphometric evidence for bone resorption and replacement in prostate cancer

1 reference

12 December 2020

Treatment of bone metastases from breast cancer and myeloma with pamidronate.

1 reference

12 December 2020

Pathophysiologic interactions in skeletal metastasis

1 reference

12 December 2020

Bone metastases: pathophysiology and management policy

1 reference

12 December 2020

Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: a preliminary report

1 reference

12 December 2020

Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer

1 reference

12 December 2020

The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer

1 reference

12 December 2020

Treatment of painful prostatic bone metastases with oral etidronate disodium

1 reference

12 December 2020

Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo

1 reference

12 December 2020

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

1 reference

12 December 2020

Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

1 reference

12 December 2020

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

1 reference

12 December 2020

Biphosphonates as an adjunct to palliative therapy of bone metastases from prostatic carcinoma. A pilot study on clodronate

1 reference

12 December 2020

Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

1 reference

12 December 2020

Strontium-89 combined with doxorubicin in the treatment of patients with androgen-independent prostate cancer

1 reference

12 December 2020

Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases

1 reference

12 December 2020

Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans.

1 reference

12 December 2020

Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.

1 reference

12 December 2020

Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo

1 reference

12 December 2020

Mechanisms of lytic and blastic metastatic disease of bone

1 reference

12 December 2020

Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the Skeleton

1 reference

12 December 2020

Short-term metabolic effects of pamidronate in patients with prostatic carcinoma and bone metastases

1 reference

12 December 2020

Subjective and metabolic effects of clodronate in patients with advanced breast cancer and symptomatic bone metastases

1 reference

12 December 2020

[Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia]

1 reference

12 December 2020

The management of intractable bone pain: a clinician's perspective

1 reference

12 December 2020

Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.

1 reference

12 December 2020

Bone metastases in breast cancer, prostate cancer and myeloma.

1 reference

12 December 2020

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

1 reference

12 December 2020

Samarium-153 EDTMP therapy of disseminated skeletal metastasis

1 reference

12 December 2020

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

1 reference

12 December 2020

Detection and clinical importance of micrometastatic disease

1 reference

12 December 2020

Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89

1 reference

12 December 2020

Relative efficacy of 32P and 89Sr in palliation in skeletal metastases

1 reference

12 December 2020

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway

1 reference

12 December 2020

Samarium-153-EDTMP in bone metastases.

1 reference

12 December 2020

Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats

1 reference

12 December 2020

The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution

1 reference

12 December 2020

Treatment of metastatic bone pain with strontium-89

1 reference

12 December 2020

Molecular mechanisms of action of bisphosphonates.

1 reference

12 December 2020

[A strontium-89 injection: a simple treatment of painful bone metastases in patients with prostate cancer unresponsive to hormonal treatment]

1 reference

12 December 2020

The pharmacology of bisphosphonates and new insights into their mechanisms of action

1 reference

12 December 2020

Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization

1 reference

12 December 2020

Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.

1 reference

12 December 2020

Sr-89 therapy for metastatic bone disease: scintigraphic and radiographic follow-up

1 reference

12 December 2020

High-dose intravenous pamidronate for metastatic bone pain

1 reference

12 December 2020

The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonates

1 reference

12 December 2020

Strontium 89 for palliation of bone metastases

1 reference

12 December 2020

External Beam Radiotherapy for Palliation of Pain from Metastatic Carcinoma of the Prostate

1 reference

12 December 2020

Metastases from cancer of the prostate; autopsy and roentgenological findings

1 reference

12 December 2020

Radiopharmaceuticals for bone lesions. Imaging and therapy in clinical practice.

1 reference

12 December 2020

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

1 reference

12 December 2020

The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer

1 reference

12 December 2020

Skeletal localization of samarium-153 chelates: potential therapeutic bone agents

1 reference

12 December 2020

Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton

1 reference

12 December 2020

Management options for painful carcinoma of the prostate.

1 reference

12 December 2020

The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study

1 reference

12 December 2020

1 reference

12 December 2020

Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate

1 reference

12 December 2020

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

12 December 2020

Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton

1 reference

12 December 2020

Spread of prostatic cancer to bone

1 reference

12 December 2020

Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton

1 reference

12 December 2020

Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.

1 reference

12 December 2020

Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma

1 reference

12 December 2020

89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes

1 reference

12 December 2020

Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study

1 reference

12 December 2020

Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose

1 reference

12 December 2020

Granin-A, parathyroid hormone-related protein, and calcitonin gene products in neuroendocrine prostate cancer.

1 reference

12 December 2020

Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption

1 reference

12 December 2020

Mechanisms of bone metastasis

1 reference

12 December 2020

Unsealed source therapy of painful bone metastases: an update

1 reference

12 December 2020

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study

1 reference

12 December 2020

Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases

1 reference

12 December 2020

The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates

1 reference

12 December 2020

Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group

1 reference

12 December 2020

Mechanisms of cancer metastasis to bone

1 reference

12 December 2020

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

1 reference

12 December 2020

Cancer statistics, 1996.

1 reference

12 December 2020

Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

1 reference

12 December 2020

Management of cancer pain. Pharmacology and principles of management

1 reference

12 December 2020

Short-term therapy with oral olpadronate in active Paget's disease of bone

1 reference

12 December 2020

Hormone therapy for patients with prostate carcinoma

1 reference

12 December 2020

Skeletal metastases in carcinoma

1 reference

12 December 2020

The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases

1 reference

12 December 2020

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group

1 reference

12 December 2020

Radiotherapy for Palliation of Locally Advanced Prostatic Carcinoma

1 reference

12 December 2020

Strontium-89 chloride in the treatment of bone metastases from breast cancer

1 reference

12 December 2020

Treatment of bone metastases with dichloromethylene bisphosphonate.

1 reference

12 December 2020

Isolation from urine of pyrophosphate, a calcification inhibitor

1 reference

12 December 2020

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

1 reference

12 December 2020

Strontium-89 therapy in a patient with carcinoma of unknown origin and incurable pain from bone metastases

1 reference

12 December 2020

Carcinoma of the breast metastatic to the skeleton

1 reference

12 December 2020

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

1 reference

12 December 2020

Bone formation markers and pain palliation in bone metastases treated with strontium-89

1 reference

12 December 2020

Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis

1 reference

12 December 2020

Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia

1 reference

12 December 2020

Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy

1 reference

12 December 2020

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

1 reference

12 December 2020

Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites

1 reference

12 December 2020

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

12 December 2020

Pyridinium cross-links as urinary markers of bone metastases in patients with prostate cancer

1 reference

12 December 2020

Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study

1 reference

12 December 2020

Radioisotope therapy in bone and joint disease

1 reference

12 December 2020

Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease

1 reference

12 December 2020

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer

1 reference

12 December 2020

Antiresorptive dose-response relationships across three generations of bisphosphonates

1 reference

12 December 2020

Palliation of multiple bone metastases from prostatic carcinoma with strontium-89

1 reference

12 December 2020

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

1 reference

12 December 2020

Use of Dichloromethylene Diphosphonate in Metastatic Bone Disease

1 reference

12 December 2020

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease

1 reference

12 December 2020

Correlation between bone metabolic markers and bone scan in prostatic cancer

1 reference

12 December 2020

Strontium-89 therapy for the pain of osseous metastases.

1 reference

12 December 2020

10.2165/00002512-200118120-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1019255246

0 references

1 reference